Repertoire Immune Medicines
Qiaomu Tian is a Senior Scientist at Repertoire Immune Medicines with a background in bioengineering and material science. They have extensive experience in early discovery of tolerizing vaccines for autoimmune diseases and TCR bispecifics for cancer therapy. Prior to their current role, they worked as a Postdoctoral Scholar at the University of Chicago focusing on nanofiber vaccines and small molecule oncology drugs. During their time as a Researcher PHD Student at the University of California, Riverside, they specialized in nanoparticles for tissue regeneration and drug delivery. Qiaomu Tian has a proven track record of leading research projects, identifying novel targets, and playing a key role in translational analytics for various diseases.
Repertoire Immune Medicines
2 followers
Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to prevent or treat cancer, as well as autoimmune and infectious disease.